A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland

Health Policy

Volumn 102, Issue 2-3, 2011, Pages 145-151

  Kolasa, Katarzyna ^a   Schubert, Sebastian ^b   Manca, Andrea ^c   Hermanowski, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b WARSAW SCHOOL OF ECONOMICS   (Poland)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

HTA; Poland; Policymaking; Reimbursement

Indexed keywords

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; DRUG INDICATION; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; POLAND; PRESCRIPTION; REIMBURSEMENT;

COSTS AND COST ANALYSIS; DECISION MAKING; HEALTH POLICY; HEALTH PRIORITIES; HEALTH SERVICES RESEARCH; HUMANS; POLAND; POLICY MAKING; PRESCRIPTION DRUGS; REIMBURSEMENT MECHANISMS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 80052805860     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2011.05.001     Document Type: Article

References (36)

1. Bodenheimer T. High and rising health care costs. Part 2: technologic innovation. Annals of Internal Medicine 2005, 142:932-937.
2. Jönsson B. Health Technology Assessment: regulators or payers-who will take the lead?. Clinical Therapeutics 2008, 30(5):960-963.
3. Scott H.J. Moskowitz Health Technology Assessment in Canada and the United States: the case of Biologics. Biotechnology Healthcare 2007, April:47-51.
4. International Network of Agencies for Health Technology Assessment (INAHTA). Available at Access on 10 September 2008. http://www.inahta.org/HTA/.
5. Andradas E., Blasco J.A., Valentin B., Lopez-Pedraza M.J., Gracia F.J. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers. International Journal of Technology Assessment in Health Care 2008, 24:60-69.
6. Velasco-Garrido M., Busse R. Health technology assessment. An introduction to objectives, role of evidence, and structure in Europe. Policy brief 2005, World Health Organization: European Observatory on Health Systems and Policies.
7. Hailey D, Babidge W, Cameron A., Davignon LA, HTA agencies and decision makers. An INAHTA guidance document. http://www.inahta.org/upload/HTA_resources/HTA%2520%2520Decision%2520Makers.pdf.
8. Wanke M., Juzwishin D., Thornley R., Chan L. An exploratory review of evaluations of Health Technology Assessment Agencies 2006, Alberta Heritage, Albert.
9. Jacob R., McGregor M. Assessing the impact of health technology assessment. International Journal of Technology Assessment in Health Care 1997, 13(1):68-80.
10. Ordinance of the Minister of Health, dated 30 June 2005, with regard to the establishment of a Health Technology Assessment Agency (Journal of Laws No. 10, item 53).
11. Act of law dated 25 June 2009 amending the law on health care services financed from the public funds and the law on pricing (O.J. 2009, No. 118, pos. 989).
12. AHTAPol President ordinance dated 4 January 2010 regarding guidance on HTA assessment. http://www.aotm.gov.pl/.
13. Law on prices dated 5 July 2001 (Journal of Laws No. 97, item 1050).
14. Law on Health Care Services Financed from Public Sources, dated 27 August 2004 (Journal of Laws No. 210, item 2135).
15. Raftery J. Review of NICE's recommendations, 1999-2005. BMJ 2006, 332:1266-1268.
16. Regulation of the Minister of Health, dated 8 December 2009, with regard to a list of basic drugs and list of supplementary drugs with their level of reimbursement (O.J 2009 No. 212, item 1646).
17. Regulation of the Minister of Health, dated 8 December 2009, with regard to a list of health problems and drug technologies indicated for these diseases with their level of reimbursement (O.J. 2009 No. 212, item 1647).
18. Regulation of the Minister of Health dated 11 January 2010 regarding guaranteed services in the area of health programs (O.J. 2010 No. 5, item 29).
19. http://www.aotm.gov.pl/.
20. Gerhardus A, Dintsios CM. The impact of HTA reports on health policy: a systematic review. GMS Health Technology Assessment. 2005. Available at Access on 7 April 2008. http://www.egms.de/en/journals/hta/2005-1/hta000002.shtml.
21. Eddama O., Coast J. A systematic review of the use of economic evaluation in local decision-making. Health Policy 2008, 86:129-141.
22. Marcial Velasco Garrido, et al. Health Technology Assessment and Health-Policy Making in Europe, Europen Observatory of Health Systems and Policies/EunetHTA. Available at http://www.euro.who.int/__data/assets/pdf_file/0003/90426/E91922.pdf.
23. Goddard M., Hauck K., Smith P. Priority setting in health - a political economy. Health Economics, Policy and Law 2006, 1:79-90.
24. Hailey D. Elements of effectiveness for health technology assessment programs. Alberta Heritage Foundation for Medical Research 2003, Alberta Heritage Foundation for Medical Research, Initiative #9. A.B. Edmonton (Ed.).
25. Sorenson C., Drummond M., Kristensen F., Busse R. How can the impact of health technology assessments be enhanced? 2008, World Health Organization.
26. Drummond M., et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force Report. Value in Health 2009, 12(4):409-418.
27. Hutton J. Harmonization of evidence requirements for health technology assessment in reimbursement decision making. International Journal of Technology Assessment in Health Care 2008, 24(4):511-517.
28. Barbieri M., Hawkins N., Sculpher M. Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies. Value in Health 2009, 12(2):193-201.
29. Drummond M., Schwartz J., Jönsson B., Luce B., Neumann P., Siebert U., et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. International Journal of Technology Assessment in Health Care 2008, 24(3):244-258.
30. Access on 30 March 2009. http://www.nice.org.uk/.
31. Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems.
32. Parada A., Helgason S., Brodsky V. Disseminating HTA products. Handbook on HTA capacity building. Assessment and Research 2008, Catalan Agency for Health Technology, Barcelona, p. 62-8.
33. Jönsson B., Banta D. Management of health technologies: an international view. BMJ 1999, 319(7220):1293-1296.
34. van Velden M.E., Severens J.L., Novak A. Evaluations of Healthcare Programmes and Decision Making. Pharmacoeconomics 2005, 23(11):1075-1082.
35. Oliver A., Mossialos E., Robinson R. Health technology assessment and its influence on health-care priority setting. International Journal of Technology Assessment in Health Care 2004, 20(1):1-10.
36. Willert P. Assessment of the pharmaceutical market in Poland after accession to the European Union. European Journal of Health Economics 2007, 8:347-357.